{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:28:20Z","timestamp":1789180100785,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ajo.2024.07.038","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:49:15Z","timestamp":1722646155000},"page":"155-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Subgroup Analysis from a Phase 1\/2 Randomized Clinical Trial of 2.6% EDTA Ophthalmic Solution in Patients with Age-Related Cataract"],"prefix":"10.1016","volume":"268","author":[{"given":"TATSUYA","family":"KUBOI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROY S.","family":"CHUCK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1592-1991","authenticated-orcid":false,"suffix":"II","given":"ROBERTO","family":"PINEDA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RAJIV","family":"BHUSHAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AMIT","family":"GOSWAMY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RANDALL J.","family":"OLSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajo.2024.07.038_bib0001","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1016\/S2214-109X(20)30425-3","article-title":"Vision Loss Expert Group of the Global Burden of Disease Study. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study","volume":"9","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"9","key":"10.1016\/j.ajo.2024.07.038_bib0002","doi-asserted-by":"crossref","first-page":"e888","DOI":"10.1016\/S2214-109X(17)30293-0","article-title":"Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis","volume":"5","author":"Bourne","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"5","key":"10.1016\/j.ajo.2024.07.038_bib0003","first-page":"915","article-title":"Mechanism of calcium-induced disintegrative globulization of rat lens fiber cells","volume":"37","author":"Wang","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2024.07.038_bib0004","first-page":"120","article-title":"Multilamellar bodies as potential scattering particles in human age-related nuclear cataracts","volume":"7","author":"Gilliland","year":"2001","journal-title":"Mol Vis"},{"issue":"4","key":"10.1016\/j.ajo.2024.07.038_bib0005","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.exer.2004.05.017","article-title":"Distribution, spherical structure and predicted Mie scattering of multilamellar bodies in human age-related nuclear cataracts","volume":"79","author":"Gilliland","year":"2004","journal-title":"Exp Eye Res"},{"issue":"6","key":"10.1016\/j.ajo.2024.07.038_bib0006","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jcrs.2003.12.023","article-title":"Light scattering and optical aberrations as objective parameters to predict visual deterioration in eyes with cataracts","volume":"30","author":"Fujikado","year":"2004","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"10.1016\/j.ajo.2024.07.038_bib0007","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0886-3350(89)80002-1","article-title":"Contrast sensitivity testing: a more complete assessment of vision","volume":"15","author":"Jindra","year":"1989","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ajo.2024.07.038_bib0008","series-title":"Causes and Coping with Visual Impairment and Blindness","first-page":"57","article-title":"Glare and ocular diseases","author":"Diep","year":"2018"},{"issue":"4","key":"10.1016\/j.ajo.2024.07.038_bib0009","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3928\/1081-597X-19980701-05","article-title":"Corneal aberrations and visual performance after radial keratotomy","volume":"14","author":"Applegate","year":"1998","journal-title":"J Refract Surg"},{"issue":"16","key":"10.1016\/j.ajo.2024.07.038_bib0010","doi-asserted-by":"crossref","first-page":"10376","DOI":"10.3390\/ijerph191610376","article-title":"Levels of trace elements in the lens, aqueous humour, and plasma of cataractous patients\u2014a narrative review","volume":"19","author":"Micun","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"10.1016\/j.ajo.2024.07.038_bib0011","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/10717540902896362","article-title":"Assessment of methylsulfonylmethane as a permeability enhancer for regional EDTA chelation therapy","volume":"16","author":"Zhang","year":"2009","journal-title":"Drug Deliv"},{"issue":"6","key":"10.1016\/j.ajo.2024.07.038_bib0012","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/15287394.2011.538835","article-title":"Topical metal chelation therapy ameliorates oxidation-induced toxicity in diabetic cataract","volume":"74","author":"Zhang","year":"2011","journal-title":"J Toxicol Environ Health A"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.038_bib0013","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/bjo.88.1.11","article-title":"The usefulness of Vistech and FACT contrast sensitivity charts for cataract and refractive surgery outcomes research","volume":"88","author":"Pesudovs","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2024.07.038_bib0014","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.10.7.7","article-title":"Sensitivity and stability of functional vision tests in detecting subtle changes under multiple simulated conditions","volume":"10","author":"Chen","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"11","key":"10.1016\/j.ajo.2024.07.038_bib0015","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"152","author":"Schulz","year":"2010","journal-title":"Ann Int Med"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.038_bib0016","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12886-022-02621-6","article-title":"A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances","volume":"22","author":"Pepose","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.ajo.2024.07.038_bib0017","unstructured":"The Accredited Committee Z80 for Ophthalmic Standards \/ The Vision Council Z80 Secretariat, American National Standards Institute, Inc. American National Standard for Ophthalmics - Multifocal Intraocular Lenses (ANSI\u00ae Z80.12-2007 (R2017)). Alexandria, Virginia: Approved March 26, 2007, Reaffirmed April 16, 2012, Reaffirmed December 11, 2017. Accessed April 9, 2024."},{"issue":"7","key":"10.1016\/j.ajo.2024.07.038_bib0018","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.3390\/jcm10071506","article-title":"Factors influencing contrast sensitivity function in eyes with mild cataract","volume":"10","author":"Kamiya","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.038_bib0019","first-page":"26","article-title":"Effect of cataract type and severity on visual acuity and contrast sensitivity","volume":"6","author":"Shandiz","year":"2011","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.ajo.2024.07.038_bib0020","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2147\/OPTH.S131343","article-title":"Evaluation of contrast sensitivity and other visual function outcomes in neovascular age-related macular degeneration patients after treatment switch to aflibercept from ranibizumab","volume":"11","author":"Nixon","year":"2017","journal-title":"Clin Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2024.07.038_bib0021","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/eye.2011.224","article-title":"Outcome of ranibizumab treatment in neovascular age related macula degeneration in eyes with baseline visual acuity better than 6\/12","volume":"25","author":"Williams","year":"2011","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.ajo.2024.07.038_bib0022","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0896-1549(03)00003-8","article-title":"Contrast sensitivity","volume":"16","author":"Owsley","year":"2003","journal-title":"Ophthalmol Clin North Am"},{"issue":"5","key":"10.1016\/j.ajo.2024.07.038_bib0023","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.visres.2011.01.011","article-title":"A comparison of spatial frequency tuning for the recognition of facial identity and facial expressions in adults and children","volume":"51","author":"Gao","year":"2011","journal-title":"Vision Res"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.038_bib0024","first-page":"19","article-title":"Contrast sensitivity: determining the visual quality and function of cataract, intraocular lenses and refractive surgery","volume":"17","author":"Ginsburg","year":"2006","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2024.07.038_bib0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1167\/iovs.61.6.21","article-title":"Relationship of contrast sensitivity measured using quick contrast sensitivity function with other visual functions in a low vision population","volume":"61","author":"Stalin","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2024.07.038_bib0026","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.2147\/OPTH.S367490","article-title":"Active learning to characterize the full contrast sensitivity function in cataracts","volume":"16","author":"Vingopoulos","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2024.07.038_bib0027","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1136\/bjo.2007.136978","article-title":"Correlation of lens density measured using the Pentacam Scheimpflug system with the Lens Opacities Classification System III grading score and visual acuity in age-related nuclear cataract","volume":"92","author":"Pei","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.038_bib0028","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.sjopt.2011.11.001","article-title":"Clinical applications of Scheimpflug imaging in cataract surgery","volume":"26","author":"Grewal","year":"2012","journal-title":"Saudi J Ophthalmol"},{"issue":"13","key":"10.1016\/j.ajo.2024.07.038_bib0029","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.3390\/jcm10132768","article-title":"Measuring the contrast sensitivity function in non-neovascular and neovascular age-related macular degeneration: the quantitative contrast sensitivity function test","volume":"10","author":"Vingopoulos","year":"2021","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.ajo.2024.07.038_bib0030","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1167\/iovs.17-22339","article-title":"Report from the NEI\/FDA endpoints workshop on age-related macular degeneration and inherited retinal diseases","volume":"58","author":"Csaky","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2024.07.038_bib0031","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s40123-023-00720-1","article-title":"Possible strategies to mitigate placebo or vehicle response in dry eye disease trials: a narrative review","volume":"12","author":"Montecchi-Palmer","year":"2023","journal-title":"Ophthalmol Ther"},{"issue":"9","key":"10.1016\/j.ajo.2024.07.038_bib0032","first-page":"5205","article-title":"Efficacy of a saline rinse of the ocular surface immediately upon awakening: a novel therapeutic approach for dry eye disease. ARVO Annual Meeting, 2019, Vancouver, B.C","volume":"60","author":"Postnikoff","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ajo.2024.07.038_bib0033","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jcrs.2009.03.017","article-title":"Repeatability and validity of lens densitometry measured with Scheimpflug imaging","volume":"35","author":"Kirkwood","year":"2009","journal-title":"J Cataract Refract Surg"},{"issue":"7","key":"10.1016\/j.ajo.2024.07.038_bib0034","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jcrs.2009.10.048","article-title":"Contrast sensitivity measurement with 2 contrast sensitivity tests in normal eyes and eyes with cataract","volume":"36","author":"Hong","year":"2010","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"10.1016\/j.ajo.2024.07.038_bib0035","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1109\/JBHI.2017.2708745","article-title":"New precision metrics for contrast sensitivity testing","volume":"22","author":"Dorr","year":"2018","journal-title":"IEEE J Biomed Health Inform"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424003490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424003490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T17:29:27Z","timestamp":1732642167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939424003490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":35,"alternative-id":["S0002939424003490"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2024.07.038","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subgroup Analysis from a Phase 1\/2 Randomized Clinical Trial of 2.6% EDTA Ophthalmic Solution in Patients with Age-Related Cataract","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2024.07.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}